Fetal Warfarin Syndrome

Overview of Fetal Warfarin Syndrome

Most recent studies have shown that Fetal Warfarin Syndrome shares some biological mechanisms with calcinosis, chondrodysplasia-punctata, congenital-abnormality, embryopathies, fetal-death, fetal-diseases, heart-diseases, heart-valve-disease, hemorrhage, hypoplasia, pregnancy-complications, pregnancy-complications-cardiovascular, stillbirth, teratogenic-effect, thromboembolism, thrombosis, vitamin-k-deficiency.

Among the many pathways, these few ones have gauged particular interests from scientists studying Fetal Warfarin Syndrome, and have been seen in publications frequently: Aging, Bone Mineralization, Cartilage Development, Cell Division, Central Nervous System Morphogenesis, Coagulation, Excretion, Localization, Pathogenesis, Regeneration, Secretion

Quite a number of genes have been found to play important roles in Fetal Warfarin Syndrome, such as ARSD, ARSF, ARSH, BGLAP, F2, F5, GAS6, GLA, GLB1, MGP, NAT8, PTK2, PXN, SERP1, SH3D19, STS, VKORC1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.

Fetal Warfarin Syndrome Related Genes

click to see detail information for each gene

Pathways Related to Fetal Warfarin Syndrome

This information is being compiled and will come in a future update

Related Diseases